CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice

Mengyuan Yang; Ziheng Xu; Mi Mi; Yuwei Ding; Yuefen Pan; Ying Yuan; Weijing Sun; Shanshan Weng

doi:10.20892/j.issn.2095-3941.2023.0211

CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice

Cancer Biol Med. 2023 Sep 9;20(9):640-645. doi: 10.20892/j.issn.2095-3941.2023.0211.

Authors

Mengyuan Yang^#¹, Ziheng Xu^#¹, Mi Mi¹, Yuwei Ding¹, Yuefen Pan², Ying Yuan^{1

3

4

5}, Weijing Sun⁶, Shanshan Weng^{1

3

4

5}

Affiliations

¹ Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, Chinese National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
² Department of Medical Oncology, Huzhou Central Hospital, Huzhou 313000, China.
³ Zhejiang Provincial Clinical Research Center for Cancer, Hangzhou 310009, China.
⁴ Cancer Center of Zhejiang University, Hangzhou 310058, China.
⁵ Binjiang Institute of Zhejiang University, Hangzhou 310052, China.
⁶ Department of Medical Oncology, The University of Kansas, School of Medicine, Lawrence, KS 66045, United States.

^# Contributed equally.

PMID: 37700433
PMCID: PMC10546093
DOI: 10.20892/j.issn.2095-3941.2023.0211

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Colorectal Neoplasms* / genetics
Colorectal Neoplasms* / pathology
Colorectal Neoplasms* / therapy
Humans
Medical Oncology
Precision Medicine*

Grants and funding

This study was supported by the Provincial Key R&D Program of Zhejiang Province (Grant No. 2021C03125) and the Beijing Xisike Clinical Oncology Research Foundation (Grant No. Y-tongshu2021/ms-0003).